Loading...
Antiviral Efficacy of Pralatrexate against SARS-CoV-2
Novel coronavirus (SARS-CoV-2) has caused more than 100 million confirmed cases of human infectious disease (COVID-19) since December 2019 to paralyze our global community. However, only limited access has been allowed to COVID-19 vaccines and antiviral treatment options. Here, we report the efficac...
Na minha lista:
| Udgivet i: | Biomol Ther (Seoul) |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Society of Applied Pharmacology
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094065/ https://ncbi.nlm.nih.gov/pubmed/33731494 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2021.032 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|